Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP2B2 intronic transcript 2 (ATP2B2-IT2) is a long non-coding RNA gene located within an intronic region of the ATP2B2 locus on chromosome 3 (HGNC:41310; NCBI Gene: 100874325). It is transcribed as RNA but does not encode a protein product. ATP2B2-IT2’s biological functions are currently uncharacterized in major databases and the scientific literature. There are no drugs, clinical biomarkers, or therapeutic applications associated with this transcript as of now. ATP2B2-IT2 should not be confused with ATP2B2 (ATPase plasma membrane Ca2+ transporting 2), which is a protein-coding gene encoding a plasma membrane calcium pump involved in hearing, neuronal calcium homeostasis, and related diseases such as certain forms of deafness. No evidence suggests that ATP2B2-IT2 is a therapeutic target or has established functional or clinical relevance at this time.
None known (not a protein, not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP2B2 intronic transcript 2 (ATP2B2-IT2).